Navigation Links
New Genomatica Chemical Process Targets Ailing Ethanol Assets
Date:2/24/2009

First-ever bio-manufacturing process to produce methyl ethyl ketone from renewable feedstocks proven in rapid order

SAN DIEGO, Feb. 25 /PRNewswire/ -- Researchers at Genomatica, Inc., a sustainable chemical company, have developed a bio-manufacturing process for methyl ethyl ketone (MEK), a commonly used industrial solvent with a global market valued at more than $2 billion. The rapid development breakthrough demonstrates that Genomatica's technology can repeatedly target specific chemicals that previously could only be produced from petroleum-based feedstocks. Genomatica's research proves these chemicals can be manufactured inside organisms using renewable feedstocks.

In the second half of 2008, on the heels of its first breakthrough, 1,4-Butanediol (BDO), Genomatica targeted MEK and began development. By extensively leveraging unique capabilities of Genomatica's technology platform, researchers have successfully created the first organism known to bio-manufacture MEK from sugar in the laboratory. The process converts sugar and water into this valuable chemical, most prominently used as a solvent in paints and coatings for furniture.

Genomatica executives selected MEK because it can be produced in existing ethanol manufacturing facilities left idle by a recent market contraction. Because of a recent downturn in demand for corn ethanol, many small- and mid-sized manufacturing facilities have been forced to cut production or shut down. These facilities are also facing serious concerns regarding the long-term competitive outlook for profitable ethanol production. To make better use of those investments, Genomatica developed a sustainable chemical process that would use the same equipment, temperatures and processes. With minimal additional investment, plants will be able to produce a chemical valued at significantly higher
'/>"/>

SOURCE Genomatica, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Free Webinars in Chemistry and Chemical Engineering
2. Enerkem announces first commercial-scale biofuels and biochemicals plant is entering start-up phase
3. Researcher working on destruction of chemical weapons
4. Sigma-Aldrich to Present at the 19th Annual Citi Chemicals Conference Tuesday, December 2, 2008
5. Researcher working on destruction of chemical weapons
6. Chemical Engineering Conference Highlights Energy, Biomedicine, Pharmaceuticals, Sustainability and Centennial
7. Syngenta and Metabolon Inc. in Collaborative Research Agreement for Biochemical Profiling Technology
8. New England Peptide Names Director of Chemical Development
9. Introducing the next generation of chemical reactors
10. Advanced Chemical Transport Opens Merced Facility
11. Chemical Lifecycle Management Chooses Chemical Safety's EMS Software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
(Date:12/2/2009)CAMBRIDGE, Mass., Dec. 2 TechConnect World, an event bringing together the leaders in technology development and product integration in cleantech, nanotech, biotech and MEMS, announced the December 1
(Date:12/2/2009)RESTON, Va., Dec. 2 /PRNewswire-Asia-FirstCall/ -- Emerald Dairy, Inc.,("Emerald Dairy" or the "Company") (OTC Bulletin Board: EMDY), a leading,producer and distributor of infant and children,s formul
(Date:12/2/2009)SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The world is going through,extraordinary times; markets are in turmoil and uncertainty is part of many,businesses and industries. It turns out that the pharma ind
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3
... Osteoporosis Medications, PHILADELPHIA, Oct. 27 ...may be at risk for serious atrial fibrillation (AF...dy. The research, presented at,CHEST 2008, the 74t...American College of Chest Physicians (ACCP), shows..., two common medications to prevent or slow,the oc...
...irstCall/ -- Tianyin,Pharmaceutical, Co., Inc., (A...ized traditional Chinese medicine ("TCM") based in...ill present at the Rodman & Renshaw,Annual Global ...008. The,Conference will be held on November 10th-...The Company,s presentation will take place in the ...
...tics (Nasdaq: NKTR ) announced that it will host ...Continental Hotel in New York on,Wednesday, Novemb... The,webcast portion of this event will conclude a...consist of a series of presentations and Q&A,relat... key research and,development, and industry-leadin...
Other Biology Technology:Osteoporosis Drugs Increase Risk for Heart Problems 2Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST 2Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST 3
(Date:12/4/2009)Scientists from the Royal Botanic Gardens, Kew and the Natural History Museum believe that carnivorous behaviour in plants is far more widespread than previously thought, with many commonly grown plan
(Date:12/4/2009)A major discovery is challenging accepted thinking about amyloids the fibrous protein deposits associated with diseases such as Alzheimer,s and Parkinson,s and may open up a potential new area for t
(Date:12/3/2009)The extinction of plant and animal species can be likened to emptying a museum of its collection, or dumping a cabinet full of potential medicines into the trash, or replacing every local cuisine with
Breaking Biology News(10 mins):Scientists think 'killer petunias' should join the ranks of carnivorous plants 2New therapy targets for amyloid disease 2Species down, disease up 2Species down, disease up 3Species down, disease up 4New NIST trace explosives standard slated for homeland security duty 14912 1New NIST trace explosives standard slated for homeland security duty 14912 2Smoking Contributes to Back Pain and Ineffective Surgical Treatments 61673 1Smoking Contributes to Back Pain and Ineffective Surgical Treatments 61673 2Smoking Contributes to Back Pain and Ineffective Surgical Treatments 61673 3Location Change for Department of Healths H1N1 Vaccine Clinic in Delaware County 61668 1Location Change for Department of Healths H1N1 Vaccine Clinic in Delaware County 61668 2
... Researchers at Northwestern University have pinpo...ep, raising interesting speculation over the purpo...d memory. , In a paper to be published June 8 by ...istant professor of neurobiology and physiology, s...ial for sleep regulation in the fruitfly Drosophil...
... Scientists at UCL (University College London) hav...tatus. The study, published today in Nature, shows...p their queen than those higher up the chain becau...epared to take more risks and wear themselves out....Research Council (NERC), reveals that those higher...
... Plant and animal breeders have long used hybridiz...ut does the same process happen without human aid?...ralist, Kenneth D. Whitney (Indiana University and...versity), and Loren H. Rieseberg (Indiana Universi...as adaptive trait introgression ?has a vital impac...
Other Biology News:Wasps queue for top job 2
Chicken Anti-HOXC11 Polyclonal Antibody, Unconjugated from ProSci, Inc
Rabbit Anti-Raf1 Polyclonal Antibody, Unconjugated from Abcam
Sheep Anti-Human hCG beta core fragment Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-SIT Monoclonal Antibody, Unconjugated, Clone SIT-01 from Abcam
Biology Products: